Developer docs
API playgroundTry for free, no card

Search company profiles

TECHLAB

Full company profile

uuid0009gby

Namestring
TECHLAB
Legal namestring
TECHLAB, Inc.
Websiteurl
techlab.com
Company typeenum
Private
Founded yearint
1989
Descriptiontext

TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid diagnostic tests focused on gastrointestinal, foodborne, and respiratory infectious diseases. Founded in 1989 by David Lyerly and Tracy Wilkins at the Virginia Tech Anaerobe Lab, the company has built a product portfolio centered on its QUIK CHEK rapid membrane enzyme immunoassay platform and CHEK ELISA product lines, covering C. difficile, H. pylori, fecal lactoferrin for IBD/IBS differentiation, Campylobacter, Shiga toxin-producing E. coli, intestinal parasites (Giardia, Cryptosporidium, E. histolytica), C. perfringens enterotoxin, and respiratory pathogens (S. pneumoniae, L. pneumophila via IMMUVIEW). Notable proprietary technical assets include Patent #8,343,726 protecting the C. DIFF QUIK CHEK COMPLETE assay, FDA 510(k) clearances across the portfolio, the first U.S. FDA-cleared non-invasive biomarker (lactoferrin) for IBD/IBS differentiation, USDA licensing for the GIARDIA VET CHEK veterinary assay, and the first European IVDR certification for a combined GDH plus Toxin A/B C. difficile test.

TECHLAB monetizes primarily through one-time product sales of FDA-cleared IVD test kits to clinical microbiology laboratories, hospital labs, and reference laboratories in the U.S. and globally, with pricing on a quote basis. Secondary revenue streams include contract manufacturing (leveraging ISO 13485 MDSAP certification and FDA registration) and contract research services offered to industrial and academic clients. Distribution historically relied on Alere as principal global distributor and now operates under SSI Diagnostica Group's network reaching 100 countries, supplemented by direct sales in the Nordics and U.S. as well as specialized channels for veterinary diagnostics.

The company is currently a wholly-owned subsidiary of SSI Diagnostica Group (a Danish platform backed by Adelis Equity Partners), following acquisitions by Pharos Capital Group in September 2016 and SSI Diagnostica Group in October 2022. The SSI group has executed additional acquisitions of CTK Biotech (2020) and Gulf Coast Scientific (April 2025), consolidating complementary IVD technologies including urea breath testing for H. pylori. TECHLAB employs roughly 150 people across its Blacksburg headquarters and Radford manufacturing facility.

Short descriptiontext

TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid immunoassay and ELISA diagnostic tests for gastrointestinal, foodborne, and respiratory infectious diseases. The company serves clinical laboratories, hospital labs, and reference laboratories worldwide as a subsidiary of SSI Diagnostica Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBlacksburg, United States
HQ citystring
Blacksburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro diagnostics, infectious disease testing, gastrointestinal diagnostics, rapid immunoassay kits, clinical laboratory products
Industry2 codes
PRIMARYHLAFAMAD
Microbiology & Infectious Disease Testing Laboratories
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
In Vitro Diagnostics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1In Vitro Diagnostic Products
TypeOne Time License
Description

TECHLAB designs, develops, and manufactures diagnostic test kits for infectious diseases. Revenue is generated through the sale of rapid diagnostic tests including C. difficile tests, H. pylori tests, lactoferrin tests, parasite screens, and foodborne pathogen tests to clinical laboratories and healthcare facilities.

2Contract Manufacturing
TypeProfessional Services
Description

TECHLAB is a full-service in vitro diagnostic product manufacturer with ISO MDSAP certification and FDA registration, offering manufacturing services to other companies.

3Contract Research
TypeProfessional Services
Description

TECHLAB offers research and manufacturing services for industrial and academic clients.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1QUIK CHEK
Description

TECHLAB's patented rapid diagnostic test technology platform delivering highly accurate results in approximately 30 minutes.

techlab.com
+5 more records
Core offering1 text field

TECHLAB designs, develops, and manufactures rapid in vitro diagnostic test kits for gastrointestinal and infectious diseases, including tests for C. difficile, H. pylori, parasites, intestinal inflammation (lactoferrin), foodborne pathogens, and respiratory pathogens. The company also offers ISO 13485 MDSAP-certified contract manufacturing and contract research services for industrial and academic clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced hospital C. difficile infection ratio from 1.3 to 0.3 when using C. DIFF QUIK CHEK COMPLETE as front-line test
+2 more records
Product overview1 text field

TECHLAB is a developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal and infectious diseases. The product portfolio centers on the QUIK CHEK™ rapid immunochromatographic/membrane assay platform and CHEK™ ELISA product lines. Core products include the C. DIFF QUIK CHEK COMPLETE® as a flagship GDH/toxin combination test, three lactoferrin testing formats (EZ VUE®, CHEK®, and SCAN®) for intestinal inflammation detection, H. pylori diagnostics (QUIK CHEK™ and CHEK™), IMMUVIEW® respiratory pathogen tests, Campylobacter detection assays, and comprehensive parasitology solutions including TRI-COMBO PARASITE SCREEN™ and E. HISTOLYTICA QUIK CHEK™. The company also offers SHIGA TOXIN QUIK CHEK for foodborne pathogen detection and GIARDIA VET CHEK™ for veterinary applications. Services include contract manufacturing (ISO MDSAP certified, FDA registered) and contract research for industrial and academic clients. TECHLAB operates as part of the SSI Diagnostica Group following acquisition in 2022.

Product and service1 record
1C. DIFF QUIK CHEK COMPLETE
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

SSI Diagnostica Group acquired Gulf Coast Scientific (GCS), a Florida-based IVD company specializing in Urea Breath Testing for H. pylori. This strengthens the group's gastric disease testing portfolio.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-01
Description

SSI Diagnostica Group, backed by Adelis Equity Partners, acquired TECHLAB in 2022. TECHLAB became part of the SSI Diagnostica Group which includes CTK Biotech (acquired 2020) and now Gulf Coast Scientific. Combined group has revenue of 850 mDKK (~125 mUSD) and nearly 600 employees.

3New River Valley COVID-19 Task Force
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-11-01
Description

TECHLAB partnered with the New River Valley COVID-19 Task Force to supply analyte-specific reagents (ASRs) for SARS-CoV-2 testing at $7-9 per use to expand COVID-19 testing capacity.

techlab.com
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-01-01
Description

Phoenix Lab, a full-service veterinary diagnostic laboratory based in Mukilteo, WA servicing over 850 veterinary clinics, offers TECHLAB's GIARDIA VET CHEK test.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-01-01
Description

Advanced Veterinary Laboratory (AVL), a veterinary laboratory in the Midwest, offers TECHLAB's GIARDIA VET CHEK test. AVL is one of the first veterinary labs to offer the USDA-licensed test.

6Alere Inc.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2016-09-01
Description

Alere remained the principal global distributor of TECHLAB products following the Pharos Capital acquisition. Alere distributed TECHLAB's rapid diagnostics in the enterics market globally.

techlab.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TECHLAB

In Vitro Diagnosticstechlab.com

TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid immunoassay and ELISA diagnostic tests for gastrointestinal, foodborne, and respiratory infectious diseases. The company serves clinical laboratories, hospital labs, and reference laboratories worldwide as a subsidiary of SSI Diagnostica Group.

What TECHLAB does

TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid diagnostic tests focused on gastrointestinal, foodborne, and respiratory infectious diseases. Founded in 1989 by David Lyerly and Tracy Wilkins at the Virginia Tech Anaerobe Lab, the company has built a product portfolio centered on its QUIK CHEK rapid membrane enzyme immunoassay platform and CHEK ELISA product lines, covering C. difficile, H. pylori, fecal lactoferrin for IBD/IBS differentiation, Campylobacter, Shiga toxin-producing E. coli, intestinal parasites (Giardia, Cryptosporidium, E. histolytica), C. perfringens enterotoxin, and respiratory pathogens (S. pneumoniae, L. pneumophila via IMMUVIEW). Notable proprietary technical assets include Patent #8,343,726 protecting the C. DIFF QUIK CHEK COMPLETE assay, FDA 510(k) clearances across the portfolio, the first U.S. FDA-cleared non-invasive biomarker (lactoferrin) for IBD/IBS differentiation, USDA licensing for the GIARDIA VET CHEK veterinary assay, and the first European IVDR certification for a combined GDH plus Toxin A/B C. difficile test.

TECHLAB monetizes primarily through one-time product sales of FDA-cleared IVD test kits to clinical microbiology laboratories, hospital labs, and reference laboratories in the U.S. and globally, with pricing on a quote basis. Secondary revenue streams include contract manufacturing (leveraging ISO 13485 MDSAP certification and FDA registration) and contract research services offered to industrial and academic clients. Distribution historically relied on Alere as principal global distributor and now operates under SSI Diagnostica Group's network reaching 100 countries, supplemented by direct sales in the Nordics and U.S. as well as specialized channels for veterinary diagnostics.

The company is currently a wholly-owned subsidiary of SSI Diagnostica Group (a Danish platform backed by Adelis Equity Partners), following acquisitions by Pharos Capital Group in September 2016 and SSI Diagnostica Group in October 2022. The SSI group has executed additional acquisitions of CTK Biotech (2020) and Gulf Coast Scientific (April 2025), consolidating complementary IVD technologies including urea breath testing for H. pylori. TECHLAB employs roughly 150 people across its Blacksburg headquarters and Radford manufacturing facility.

TECHLAB firmographics

Firmographics
Name
TECHLAB
Legal name
TECHLAB, Inc.
Website
https://techlab.com
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
101–250 employees
Short description
TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid immunoassay and ELISA diagnostic tests for gastrointestinal, foodborne, and respiratory infectious diseases. The company serves clinical laboratories, hospital labs, and reference laboratories worldwide as a subsidiary of SSI Diagnostica Group.
Ownership category
akta.pro rank

TECHLAB industry classification

Industry
Product category
In Vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAMAD
Microbiology & Infectious Disease Testing Laboratories
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories

Keywords

  • In vitro diagnostics
  • Infectious disease testing
  • Gastrointestinal diagnostics
  • Rapid immunoassay kits
  • Clinical laboratory products

Where TECHLAB is headquartered

Location

Headquarters

HQ city
Blacksburg
HQ country
United States
HQ region
North America

Offices3 records

Markets served

TECHLAB business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. In Vitro Diagnostic Products: TECHLAB designs, develops, and manufactures diagnostic test kits for infectious diseases. Revenue is generated through the sale of rapid diagnostic tests including C. difficile tests, H. pylori tests, lactoferrin tests, parasite screens, and foodborne pathogen tests to clinical laboratories and healthcare facilities.
  2. Contract Manufacturing: TECHLAB is a full-service in vitro diagnostic product manufacturer with ISO MDSAP certification and FDA registration, offering manufacturing services to other companies.
  3. Contract Research: TECHLAB offers research and manufacturing services for industrial and academic clients.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

TECHLAB product offering

Product offering

Core offering

TECHLAB designs, develops, and manufactures rapid in vitro diagnostic test kits for gastrointestinal and infectious diseases, including tests for C. difficile, H. pylori, parasites, intestinal inflammation (lactoferrin), foodborne pathogens, and respiratory pathogens. The company also offers ISO 13485 MDSAP-certified contract manufacturing and contract research services for industrial and academic clients.

Product overview

TECHLAB is a developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal and infectious diseases. The product portfolio centers on the QUIK CHEK™ rapid immunochromatographic/membrane assay platform and CHEK™ ELISA product lines. Core products include the C. DIFF QUIK CHEK COMPLETE® as a flagship GDH/toxin combination test, three lactoferrin testing formats (EZ VUE®, CHEK®, and SCAN®) for intestinal inflammation detection, H. pylori diagnostics (QUIK CHEK™ and CHEK™), IMMUVIEW® respiratory pathogen tests, Campylobacter detection assays, and comprehensive parasitology solutions including TRI-COMBO PARASITE SCREEN™ and E. HISTOLYTICA QUIK CHEK™. The company also offers SHIGA TOXIN QUIK CHEK for foodborne pathogen detection and GIARDIA VET CHEK™ for veterinary applications. Services include contract manufacturing (ISO MDSAP certified, FDA registered) and contract research for industrial and academic clients. TECHLAB operates as part of the SSI Diagnostica Group following acquisition in 2022.

Differentiator

Problem solved

Functional benefit

Brands

  • QUIK CHEK: TECHLAB's patented rapid diagnostic test technology platform delivering highly accurate results in approximately 30 minutes.
  • LACTOFERRIN CHEK
  • LACTOFERRIN EZ VUE
  • LACTOFERRIN SCAN
  • C. DIFF QUIK CHEK COMPLETE
  • IMMUVIEW

Products and services

  • C. DIFF QUIK CHEK COMPLETE

Quantifiable outcome

  • Reduced hospital C. difficile infection ratio from 1.3 to 0.3 when using C. DIFF QUIK CHEK COMPLETE as front-line test
  • +2 more outcomes

Companies that use TECHLAB

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

TECHLAB technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

TECHLAB partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • Gulf Coast ScientificminorStrategic or Co-development Partner · 1 April 2025SSI Diagnostica Group acquired Gulf Coast Scientific (GCS), a Florida-based IVD company specializing in Urea Breath Testing for H. pylori. This strengthens the group's gastric disease testing portfolio.
  • SSI Diagnostica GroupcoreStrategic or Co-development Partner · 1 October 2022SSI Diagnostica Group, backed by Adelis Equity Partners, acquired TECHLAB in 2022. TECHLAB became part of the SSI Diagnostica Group which includes CTK Biotech (acquired 2020) and now Gulf Coast Scientific. Combined group has revenue of 850 mDKK (~125 mUSD) and nearly 600 employees.
  • New River Valley COVID-19 Task ForceminorStrategic or Co-development Partner · 1 November 2020TECHLAB partnered with the New River Valley COVID-19 Task Force to supply analyte-specific reagents (ASRs) for SARS-CoV-2 testing at $7-9 per use to expand COVID-19 testing capacity.
  • Phoenix LabminorChannel Partner/ Reseller/ Distributor · 1 January 2018Phoenix Lab, a full-service veterinary diagnostic laboratory based in Mukilteo, WA servicing over 850 veterinary clinics, offers TECHLAB's GIARDIA VET CHEK test.
  • Advanced Veterinary LaboratoryminorChannel Partner/ Reseller/ Distributor · 1 January 2018Advanced Veterinary Laboratory (AVL), a veterinary laboratory in the Midwest, offers TECHLAB's GIARDIA VET CHEK test. AVL is one of the first veterinary labs to offer the USDA-licensed test.
  • Alere Inc.coreChannel Partner/ Reseller/ Distributor · 1 September 2016Alere remained the principal global distributor of TECHLAB products following the Pharos Capital acquisition. Alere distributed TECHLAB's rapid diagnostics in the enterics market globally.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

TECHLAB competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

TECHLAB social profiles

Digital presence

TECHLAB compliance and trust

Trust signal

Compliance1 record

TECHLAB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TECHLAB leadership team

Management profile

Number of profiles

Profiles8 records

TECHLAB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TECHLAB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TECHLAB

What does TECHLAB do?

TECHLAB designs, develops, and manufactures rapid in vitro diagnostic test kits for gastrointestinal and infectious diseases, including tests for C. difficile, H. pylori, parasites, intestinal inflammation (lactoferrin), foodborne pathogens, and respiratory pathogens. The company also offers ISO 13485 MDSAP-certified contract manufacturing and contract research services for industrial and academic clients.

Is TECHLAB a public or private company?

TECHLAB is a private company. It is classified as corporate owned and is currently operating.

When was TECHLAB founded?

TECHLAB was founded in 1989. It employs 101 to 250 people.

Where is TECHLAB based?

TECHLAB is headquartered in Blacksburg, United States, in the North America region.

How does TECHLAB make money?

Three revenue lines are on record. In Vitro Diagnostic Products are the primary driver. The others are contract Manufacturing and contract Research.

Does TECHLAB have an API?

No public API is recorded for TECHLAB.

What industry is TECHLAB in?

TECHLAB's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories, with a secondary code of HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePharos Capital Sells TechLab, Inc. to SSI DiagnosticaPharos Capital Group has sold its stake in portfolio company TechLab, Inc. to SSI Diagnostica, a diagnostics manufacturer based in Denmark and owned by Adelis Equity. This transaction marks the third exit from Pharos's third fund, with TechLab continuing to operate its U.S. facilities and retaining its existing management team. Terms of the deal were not disclosed.PR NewswireTECHLAB to Supply the New River Valley COVID-19 Task Force with Essential Reagents to Expand COVID-19 TestingTECHLAB Inc. announced a partnership with the New River Valley COVID-19 Task Force to supply analyte-specific reagents (ASRs) for SARS-CoV-2 testing at $7-9 per use, expanding the region's testing capacity. The reagents can be used by any CLIA-certified lab performing medium- and high-complexity testing, with TECHLAB also developing 96-well and rapid antigen tests for planned FDA emergency use authorization. TECHLAB manufactures its diagnostic products in-house in southwest Virginia and can supply any CLIA lab across the United States.PR NewswireTECHLAB Receives FDA 510(k) Clearance To Market H. PYLORI QUIK CHEK™ And H. PYLORI CHEK™ TestsTECHLAB, Inc. announced it received FDA 510(k) clearance to market its H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ diagnostic tests designed to aid in the diagnosis of H. pylori infection, a disease affecting half the world's population and responsible for most duodenal and gastric ulcers. The QUIK CHEK provides results in 30 minutes while the CHEK is a 96-well plate format for laboratories that can be completed in one hour. Both tests demonstrated strong clinical performance compared to histology and urease testing, and offer flexible transport conditions including room temperature storage.PR NewswireAdvanced Veterinary Laboratory To Offer GIARDIA VET CHEK™ From TECHLAB®TECHLAB, Inc. announced a supply agreement to provide Advanced Veterinary Laboratory (AVL) with its GIARDIA VET CHEK™ rapid diagnostic test, the first USDA-licensed Giardia microwell ELISA available for dogs and cats. AVL, based in St. Louis, becomes one of the first Midwest veterinary laboratories to offer the test, which delivers results in 90 minutes with strong diagnostic performance. Giardia is a common parasitic cause of diarrhea in companion animals, representing a routine diagnostic need in the veterinary market.PR NewswireTECHLAB® Receives FDA 510(k) Clearance To Market TRI-COMBO PARASITE SCREEN™ To Aid Clinicians In The Diagnosis Of Giardiasis, Cryptosporidiosis, And AmebiasisTECHLAB®, Inc. announced it received U.S. Food and Drug Administration 510(k) clearance for the TRI-COMBO PARASITE SCREEN™ test, which simultaneously detects Giardia, Cryptosporidium, and Entamoeba histolytica antigens in human fecal specimens. The enzyme immunoassay is indicated as an aid in diagnosing giardiasis, cryptosporidiosis, and amebiasis, the three most common parasitic causes of diarrhea in the United States. According to the company, this new assay makes testing for the three most common causes of parasitic gastroenteritis more efficient and cost-effective.